Nurix (NRIX) legal chief sells shares to cover RSU taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics Chief Legal Officer Christine Ring reported RSU vesting and related share sales. On January 30, 2026, multiple blocks of restricted stock units were converted into common stock at an exercise price of $0, increasing her directly held common shares.
On the same date, she sold 4,333 and 88 common shares at weighted average prices of $16.5826 and $17.3717, respectively. A footnote explains these sales were mandated "sell to cover" transactions to satisfy tax withholding on RSU vesting, not discretionary trades. After these transactions, she directly owned 57,010 common shares and held 25,725 RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,421 shares ($73,381)
Net Sell
10 txns
Insider
Ring Christine
Role
Chief Legal Officer
Sold
4,421 shs ($73K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,925 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,750 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,859 | $0.00 | -- |
| Exercise | Common Stock | 1,925 | $0.00 | -- |
| Exercise | Common Stock | 2,000 | $0.00 | -- |
| Exercise | Common Stock | 3,750 | $0.00 | -- |
| Exercise | Common Stock | 2,859 | $0.00 | -- |
| Sale | Common Stock | 4,333 | $16.5826 | $72K |
| Sale | Common Stock | 88 | $17.3717 | $2K |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 52,822 shares (Direct)
Footnotes (1)
- The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Represents the weighted average sale price. The lowest price at which shares were sold was $16.33 and the highest price at which shares were sold was $17.32. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Represents the weighted average sale price. The lowest price at which shares were sold was $17.33 and the highest price at which shares were sold was $17.49. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in substantially equal increments quarterly over four years, with the first quarterly increment vesting on April 30, 2022, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. RSUs do not expire; they either vest or are canceled prior to the vest date. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2023, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
